ClinConnect ClinConnect Logo
Search / Trial NCT06286813

The Effect of Almond and Extra Virgin Olive Oils on Maintaining Skin Integrity in Neonates

Launched by MARMARA UNIVERSITY · Feb 22, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Newborn, Skin Care, Extra Virgin Olive Oil, Almond Oil.

ClinConnect Summary

This clinical trial is studying how almond oil and extra virgin olive oil can help keep the skin of newborns healthy while they are in the neonatal intensive care unit (NICU). The researchers want to see if these natural oils can improve skin integrity, which is important for the overall health of babies, especially those who are premature or have other health challenges.

To participate in the study, newborns must be between 0 and 3 days old, born at a healthy gestational age of 37 to 42 weeks, and expected to stay in the NICU for at least five days. Parents must also give their written and verbal consent for their babies to be part of the trial. If a baby is discharged before five days or needs special light treatment (phototherapy), they will not be included in the study. Families involved can expect their baby to receive either almond oil or olive oil during their NICU stay, and the researchers will monitor how these oils affect their baby’s skin. This study is currently looking for participants and aims to provide helpful information about skin care for vulnerable newborns.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Neonates who were born at 37-42 weeks of gestation, were planned to be hospitalized in the NICU for at least 5 days, had a post-natal age of 0-72 hours, and were received written and verbal consent from parents were included in the study.
  • Exclusion Criteria:
  • ; Neonates who were discharged before 5 days and required phototherapy were excluded from the study.

About Marmara University

Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

AYŞE KARAKOÇ

Study Director

Marmara University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported